AP NEWS
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Globe Newswire
Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Entasis Therapeutics to Present at H.C. Wainwright & Co. Global Life Sciences Conference in London

April 2, 2019

WALTHAM, Mass., April 02, 2019 (GLOBE NEWSWIRE) -- Entasis Therapeutics Holdings Inc. (NASDAQ: ETTX), a clinical-stage biopharmaceutical company focused on the discovery and development of novel antibacterial products, today announced that Dr. Manos Perros, President and Chief Executive Officer, will present at the H.C, Wainwright & Co. Global Life Sciences Conference being held April 7-9, 2019 in London, UK.

Details of the presentation are below:Event: H.C. Wainwright & Co. Global Life Sciences ConferenceDate: Tuesday, April 9, 2019Time: 11:10 AM GMT / 7:10 AM EDT

In addition to his presentation, Dr. Perros will be hosting 1-on-1 investor meetings at the conference. Investors attending the conference who are interested in meeting with Entasis management should contact their H.C. Wainwright representatives.

About EntasisEntasis is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multidrug-resistant Gram-negative bacteria. Entasis’ targeted-design platform has produced a pipeline of product candidates, including ETX2514SUL (targeting A. baumannii infections), zoliflodacin (targeting Neisseria gonorrhoeae), and ETX0282CPDP (targeting Enterobacteriaceae infections). Entasis is also using its platform to develop a novel class of antibiotics, non-β-lactam inhibitors of the penicillin-binding proteins (NBPs) (targeting Gram-negative infections). For more information, visit www.entasistx.com.

Entasis Company Contact Kyle Dow Entasis Therapeutics (781) 810-0114 kyle.dow@entasistx.com

Investor Relations ContactLee RothThe Ruth Group(646) 536-7012 lroth@theruthgroup.com

Media ContactKirsten ThomasThe Ruth Group(508) 280-6592 kthomas@theruthgroup.com